Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Korte, Erik A ^a   Gaffney, Patrick M ^b   Powell, David W ^a  

^a University of Louisville School of Medicine   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 1 MICROGLOBULIN; ALPHA CRYSTALLIN; ALPHA TUBULIN; APOLIPOPROTEIN A4; BETA TUBULIN; BIOLOGICAL MARKER; BRAIN ACID SOLUBLE PROTEIN; CALGRANULIN; CALPHOBINDIN II; CARBOXYLESTERASE; CERULOPLASMIN; FRUCTOSE BISPHOSPHATE ALDOLASE ISOENZYME; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN ALPHA2; HEAT SHOCK PROTEIN; HEPCIDIN 20; IMMUNOGLOBULIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERMEDIATE FILAMENT ALPHA INTERNEXIN; LIPOCALIN; OROSOMUCOID; PROTEIN S100 A12; PROTEIN S100 P; PROTEIN S100B; RESISTIN; RO52 PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN SUBFAMILY 1A; PROTEOME;

CARDIOMYOPATHY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; IMMUNOCOMPETENT CELL; LIQUID CHROMATOGRAPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84857439994     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3701     Document Type: Review

References (71)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Góral A, de Ramón E, Fernández-Nebro A, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ruiz-Irastorza G, Ingelmo M, Hughes GR. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999, 78:167-175.
2. Molino C, Fabbian F, Longhini C. Clinical approach to lupus nephritis: recent advances. Eur J Intern Med 2009, 20:447-453.
3. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
4. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 1999, 17:676-682.
5. Powell DW, Merchant ML, Link AJ. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry. Expert Rev Proteomics 2006, 3:63-74.
6. Powell DW, Rane MJ, Joughin BA, Kalmukova R, Hong J-H, Tidor B, Dean WL, Pierce WM, Klein JB, Yaffe MB, McLeish KR. Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol 2003, 23:5376-5387.
7. Clarke CH, Buckley JA, Fung ET. SELDI-TOF-MS proteomics of breast cancer. Clin Chem Lab Med 2005, 43:1314-1320.
8. Lu X-Y, Chen X-X, Huang L-D, Zhu C-Q, Gu Y-Y, Ye S. Antialpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis. PLoS ONE 2010, 5:e11124.
9. Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Oyama M, Kozuka-Hata H, Hattori H, Nagata K, Yamanaka H, Hara M. Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches. Mol Cell Proteomics 2011, 10:M110.005330.
10. Seko Y, Matsumoto A, Fukuda T, Imai Y, Fujimura T, Taka H, Mineki R, Murayama K, Hirata Y, Nagai R. A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6. Int Heart J 2007, 48:407-415.
11. Appenzeller S, Pineau C, Clarke A. Acute lupus myocarditis: Clinical features and outcome. Lupus 2011, 20:981-988.
12. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002, 113:419-423.
13. Comín-Colet J, Sánchez-Corral MA, Alegre-Sancho JJ, Valverde J, López-Gómez D, Sabaté X, Juan-Mas A, Esplugas E. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Lupus 2001, 10:59-62.
14. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980, 69:849-858.
15. Gazarian M, Feldman BM, Benson LN, Gilday DL, Laxer RM, Silverman ED. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998, 132:109-116.
16. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408-415.
17. Kurien BT, Newland J, Paczkowski C, Moore KL, Scofield RH. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol 2000, 120:209-217.
18. Wang L, Dai Y, Qi S, Sun B, Wen J, Zhang L, Tu Z. Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol Int 2010,
19. Ottosson L, Salomonsson S, Hennig J, Sonesson S-E, Dörner T, Raats J, Kuchroo VK, Sunnerhagen M, Wahren-Herlenius M. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Scand J Immunol 2005, 61:109-118.
20. Serada S, Fujimoto M, Takahashi T, He P, Hayashi A, Tanaka T, Hagihara K, Yamadori T, Mochizuki M, Norioka N, . others Proteomic analysis of autoantigens associated with systemic lupus erythematosus: Anti-aldolase A antibody as a potential marker of lupus nephritis. Proteomics Clin Appl 2007, 1:185-191. others.
21. Reed JH, Neufing PJ, Jackson MW, Clancy RM, Macardle PJ, Buyon JP, Gordon TP. Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes. Clin Exp Immunol 2007, 148:153-160.
22. Briassouli P, Komissarova EV, Clancy RM, Buyon JP. Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block. Circ Res 2010, 107:374-387.
23. Pavon EJ, Munoz P, Lario A, Longobardo V, Carrascal M, AbiÃin J, Martin AB, Arias SA, Callejas-Rubio JL, Sola R, Navarro-Pelayo F, Raya-Alvarez E, Ortego-Centeno N, Zubiaur M, Sancho J. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006, 6(Suppl 1):S282-S292.
24. Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004, 345:35-42.
25. Chapelle JP, Albert A, Smeets JP, Heusghem C, Kulbertus HE. Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982, 307:457-463.
26. Gunteski-Hamblin AM, Song G, Walsh RA, Frenzke M, Boivin GP, Dorn GW 2, Kaetzel MA, Horseman ND, Dedman JR. Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol 1996, 270:H1091-1100.
27. Dai Y, Hu C, Huang Y, Huang H, Liu J, Lv T. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 2008, 17:799-804.
28. Yi L, Zeng X, Tan H, Ge L, Ji X-X, Lin M, Su Q. Proteomics analysis of apoptosis initiation induced by diallyl disulfide in human leukemia HL-60 cells. Ai Zheng 2009, 28:33-37.
29. Ohsawa S, Watanabe T, Katada T, Nishina H, Miura M. Novel antibody to human BASP1 labels apoptotic cells post-caspase activation. Biochem Biophys Res Commun 2008, 371:639-643.
30. Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 2010, 19:557.
31. Kimura A, Kanoh Y, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T. Antibodies in patients with neuropsychiatric systemic lupus erythematosus. Neurology 2010, 74:1372.
32. Kimura A, Sakurai T, Yamada M, Koumura A, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T. Elevated anti-heat shock protein 60 antibody titer is related to white matter hyperintensities. J Stroke Cerebrovasc Dis 2010,
33. Reyes-Thomas J, Blanco I, Putterman C. Urinary biomarkers in lupus nephritis. Clin Rev Allerg Immunol 2010, 40:138-150.
34. Oates JC, Varghese S, Bland AM, Taylor TP, Self SE, Stanislaus R, Almeida JS, Arthur JM. Prediction of urinary protein markers in lupus nephritis. Kidney Int 2005, 68:2588-2592.
35. Mosley K, Tam FWK, Edwards RJ, Crozier J, Pusey CD, Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 2006, 45:1497-1504.
36. Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu C-Y, Hebert LA, Rovin BH. Biomarker discovery for lupus nephritis through longitudinal urine proteomics. Kidney Int 2008, 74:799-807.
37. Zhang X, Rovin BH. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta 2010, 1800:1262-1267.
38. Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, Devarajan P, Brunner HI. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol 2007, 22:2047-2057.
39. Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, Olson J, Onel K, O'Neil KM, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009, 65:530-536.
40. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007, 18:913-922.
41. Dong J, Li H, Wang J-B, Yao Y, Yang Q-R. Predictors for neuropsychiatric development in Chinese adolescents with systemic lupus erythematosus. Rheumatol Int 2011,
42. Sibbitt WL, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002, 29:1536-1542.
43. Ndhlovu M, Preuss BE, Dengjel J, Stevanovic S, Weiner SM, Klein R. Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus. Brain Behav Immun 2011, 25:279-285.
44. Zhang Y, Wang J, Xiang D, Wang D, Xin X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int J Oncol 2009, 35:1069-1079.
45. Kimura A, Sakurai T, Tanaka Y, Hozumi I, Takahashi K, Takemura M, Saito K, Seishima M, Inuzuka T. Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI. Lupus 2008, 17:16-20.
46. Johnson RB, Fearon K, Mason T, Jindal S. Cloning and characterization of the yeast chaperonin HSP60 gene. Gene 1989, 84:295-302.
47. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, Epstein SE. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001, 103:1071-1075.
48. Kao S-H, Hsu T-C, Yu J-S, Chen J-T, Li S-L, Lai W-X, Tzang B-S. Proteomic analysis for the anti-apoptotic effects of cystamine on apoptosis-prone macrophage. J Cell Biochem 2010, 110:660-670.
49. Dardik R, Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 2006, 312:2973-2982.
50. Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex. J Neurochem 2008, 107:941-951.
51. D'souza A, Kurien BT, Rodgers R, Shenoi J, Kurono S, Matsumoto H, Hensley K, Nath SK, Scofield RH. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 2008, 9:62.
52. Ye S, Pang H, Gu YY, Hua J, Chen XG, Bao CD, Wang Y, Zhang W, Qian J, Tsao BP, . others Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology 2003, 42:1155. others.
53. Walters E, Rider V, Abdou NI, Greenwell C, Svojanovsky S, Smith P, Kimler BF. Estradiol targets T cell signaling pathways in human systemic lupus. Clin Immunol 2009, 133:428-436.
54. Pachner AR, Warth JD, Pace A, Goelz S. Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. Neurology 2009, 73:1493-1500.
55. Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 2011, 70:2029-2036.
56. Pan X, Huang L, Chen J, Dai Y, Chen X. Analysis of synovial fluid in knee joint of osteoarthritis:5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Int Orthop 2012, 36:57-64.
57. Dieudé M, Senécal J-L, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004, 50:3221-3231.
58. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995, 96:2569-2577.
59. Qazi KR, Torregrosa Paredes P, Dahlberg B, Grunewald J, Eklund A, Gabrielsson S. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 2010, 65:1016-1024.
60. Fietta A, Bardoni A, Salvini R, Passadore I, Morosini M, Cavagna L, Codullo V, Pozzi E, Meloni F, Montecucco C. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther 2006, 8:R160.
61. Rottoli P, Magi B, Cianti R, Bargagli E, Vagaggini C, Nikiforakis N, Pallini V, Bini L. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005, 5:2612-2618.
62. Bargagli E, Penza F, Vagaggini C, Magi B, Perari MG, Rottoli P. Analysis of carbonylated proteins in bronchoalveolar lavage of patients with diffuse lung diseases. Lung 2007, 185:139-144.
63. Bargagli E, Olivieri C, Prasse A, Bianchi N, Magi B, Cianti R, Bini L, Rottoli P. Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation 2008, 31:351-354.
64. Tamburro D, Facchiano F, Petricoin EF, Liotta LA, Zhou W. Mass spectrometrybased characterization of the vitreous phosphoproteome. Proteomics Clin Appl 2010, 4:839-846.
65. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009, 3:33-44.
66. Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, Roubenoff R, Zolg W, Guild BC. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:3792-3803.
67. Whiteaker JR, Zhao L, Abbatiello SE, Burgess M, Kuhn E, Lin C, Pope ME, Razavi M, Anderson NL, Pearson TW, Carr SA, Paulovich AG. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics 2011, 10:M110.005645.
68. Beck LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361:11-21.
69. Bhinder S, Singh A, Majithia V. Membranous (class V) renal disease in systemic lupus erythematosus may be more common than previously reported: results of a 6-year retrospective analysis. Am J Med Sci 2010, 339:230-232.
70. Li T-W, Zheng B-R, Huang Z-X, Lin Q, Zhao L-K, Liao Z-T, Zhao J-J, Lin Z-M, Gu J-R. Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study. Chin Med J 2010, 123:537-543.
71. Cui Y, Huang M, He Y, Zhang S, Luo Y. Genetic ablation of apolipoprotein A-IV accelerates Alzheimer's disease pathogenesis in a mouse model. Am J Pathol 2011, 178:1298-1308.